• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Hemogenyx Pharmaceuticals PLC (HEMO)

ORD GBP0.01
Sell: 649.00p|Buy: 680.00p|Change: 19.00 (2.89%)

Open 

626.365p

Previous close 

658.00p

Trade high 

690.00p

Volume 

9,391

Year high 

1,220.00p

Year low 

356.00p

Dividend yield 

–

Market capitalisation 

£46.69 mn

P/E ratio 

–

ISIN 

GB00BQVXM815

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Share price

Performance 16/10/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Hemogenyx Pharmaceuticals PLC+ 7.17
More...

Company profile

Hemogenyx Pharmaceuticals PLC is clinical-stage biotechnology focused on the discovery, development and commercialisation of treatments relating to the treatment of blood cancers, certain solid cancers, autoimmune diseases, and viral infections. The products under development are designed to address a range of problems that occur with current standard of care treatments. The Group has one reportable segment, the discovery, development, and commercialisation of treatments relating to blood and immune system disorders and viral infections, and administrative functions in the United Kingdom. It has its presence in United Kingdom; and United States.

Sector 

Healthcare

News

Recent trades

DateTimePriceQuantityValue (£)
19/10/202611:33:196774753,215.75
19/10/202610:37:566782,05413,926.12
19/10/202610:07:436821471,002.54
19/10/202609:57:3069015100.73
19/10/202609:57:2769036248.83

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.